A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy. - Chen, Zude; Yang, Xiaoshuang; Chen, Zugen; Li, Minzhao; Wang, Wei; Yang, Riwei; Wang, Zuomin; Ma, Yuxiang; Xu, Yulong; Ao, Shan; Liang, Leqi; Cai, Chao; et al. (BMC Medicine, 2023)